Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
about
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoraminClonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skinClonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activationClonidine in paediatric anaesthesia.Pheochromocytoma: an approach to antihypertensive management.Newer beta blockers and the treatment of hypertension.Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.High-dose clonidine in a case of restless legs syndrome.Presynaptic alpha-adrenoreceptors; in vitro methods and preparations utilised in the evaluation of agonists and antagonists.Review of therapeutic modalities acting directly via central pathways.Vasodilators.Prazosin partly blocks clonidine-induced hypotension in patients with essential hypertension.Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.Adverse interaction between clonidine and verapamil.Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction.Differential effects of oral beta blockade on cardiovascular and sympathetic regulation.The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting.Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine.Oral clonidine premedication for elderly patients undergoing intraocular surgery.Presence and physiological role of presynaptic inhibitory alpha 2-adrenoreceptors in guinea pig atria.The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.Alpha-Adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors.The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.Oral premedication with clonidine: effects on stress responses during general anaesthesia.Oral clonidine premedication does not alter the efficacy of epidural test doses in adult patients anesthetized with isoflurane.Clonidine decreases vasoconstriction and shivering thresholds, without affecting the sweating threshold.Enhancement of pressor response to ephedrine following clonidine medication.Effects of intrathecal clonidine on duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia in patients undergoing knee arthroscopy.Effects of oral clonidine premedication on concentrations of cortisol and monoamine neurotransmitters and their metabolites in cerebrospinal fluid and plasma.Effect of clonidine on haemodynamic responses to endotracheal intubation and on gastric acidity.R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
P2860
Q24674082-B84D523D-4611-4BEC-AF63-A81A4B9FE995Q28184792-5DD99D78-00DB-439C-9CEA-1ADDFE7099B2Q28362700-832666B9-C836-4E1E-9447-7F6EB773DD8EQ33631266-9112F655-73F0-40AD-B706-B471BBC703CAQ34967562-B7CFA195-99D5-455A-8FC1-F536B8587EA5Q36514083-A718FCA5-A9F7-4B28-9156-AC2F89B9EA27Q36552496-E94B2956-8C3C-4A0A-9F4C-C442AE4B2AE9Q36686822-101546FD-FB3B-4BE8-9953-1597256AC4FAQ39483482-AD16AE24-FFCB-43DD-8FA6-69A5FD6BEEBEQ40086859-C21198CB-1B1B-4549-B880-181E258E17D1Q40087562-2D03E995-83DA-43A1-9116-F6264C88A1A0Q40155306-D576FD07-E6DE-465C-97E6-EA18F2EE94CCQ42206708-6BB30116-BBCF-41B0-8F62-512EA181454CQ42277099-B73DEEED-140B-44AA-9124-73748B038909Q42282303-5AE83B8A-740D-4389-B990-E7EF3023F0BFQ42450906-3EE61731-6DE2-45AC-8AE6-9F0A94BA7098Q43244754-6E3AA807-9DB9-48DF-8D1A-5A851974CC1FQ43511539-D5EDC181-5217-4972-95F6-3E6857171990Q43716091-C98118D4-6E83-448D-98E7-9CA7F3124F06Q44239591-7A5C5F8A-A0AA-4BA4-A8CE-B84CFE3AD34FQ46429126-2C5EEA61-E4A0-4DFB-A0C3-5231D22B3D63Q48973669-60548F0B-B367-4A9B-8F2A-E23F3FEF054AQ49127113-A906A1B5-FA8E-4B7F-A87C-D202A8CD0514Q49130443-F9377E2F-588E-4B36-A2C1-3751EB847333Q51154893-4D552B7F-2C9F-437C-85C8-AD6A68AAB75BQ51194482-D30CAC39-7B35-4C1C-AF31-3CB470F9954CQ51540741-D063927B-3CC6-4707-A890-1DEB0AB22BCEQ51541954-8C72A2A4-0EF9-4B77-B646-B4BA8E59E33FQ51578607-BA269627-1722-467D-A326-01AF9D1A24BCQ51624143-9AF34D95-02B0-4865-8678-C5E2A1ED521AQ51757700-250EF592-DC5C-4C38-9BFC-A2CD5FEB1C20Q51790952-FE9DF2D5-E27F-42CB-8975-7126A0316C8FQ53917502-24E4E00E-5028-4A94-839C-93FAB02F36BA
P2860
Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Recent developments in noradre ...... rtain antihypertensive agents.
@en
type
label
Recent developments in noradre ...... rtain antihypertensive agents.
@en
prefLabel
Recent developments in noradre ...... rtain antihypertensive agents.
@en
P2093
P356
P1433
P1476
Recent developments in noradre ...... rtain antihypertensive agents.
@en
P2093
R Massingham
S Z Langer
P304
P356
10.1161/01.HYP.2.4.372
P407
P577
1980-07-01T00:00:00Z